All-In's Best Ideas Pitch Competition: 4 Investors Present Their Top Trades Live

Episode Overview

• This episode replicates the spirit of the Sohn Investment Conference, bringing together top asset managers to pitch highly asymmetric investment ideas across hard assets, biotechnology, and decentralized technology.
• The discussion spans a structural value thesis in nuclear-powered data centers, a long-term growth opportunity in underpriced gaming and resort assets, and the transformative potential of precision oncology.
• The conversation also covers the rise of physical AI, demonstrating how decentralized hardware networks can disrupt legacy telecommunications and satellite positioning systems.
• This content is highly relevant for investors, technology enthusiasts, and healthcare professionals seeking to understand how massive structural shifts—specifically in AI energy demands, cancer therapeutics, and localized positioning data—are shaping the future of global industries.

Key Concepts

• Asymmetric Risk/Reward in Hard Assets vs. Replacement Cost: This value-investing framework involves buying essential, globally needed hard assets at a significant discount to their physical replacement cost. When supply constraints meet rising demand, the market eventually values the asset at or above replacement cost, offering a massive margin of safety.
• The Structural Shift in Power Demand (AI & Data Centers): Power demand, which historically grew at GDP rates, is entering a structural expansion phase driven by AI, manufacturing onshoring, and electrification. Because AI computing acts like a commodity refinery—converting electricity into intelligence—existing clean, baseload power producers (specifically nuclear) hold immense pricing power due to severe grid connection bottlenecks.
• Precision Radiopharmaceuticals as the "Drones" of Oncology: Moving away from broad-spectrum chemotherapy and radiation, modern radiopharmaceuticals use molecular targeting to deliver highly localized radioactive payloads directly to cancer cells. This "micro-drone" approach offers the therapeutic power of radiation with a blast radius of a single cell, minimizing collateral damage to healthy tissue.
• The Theranostic and Geopolitical Moats in Biotech: Radiopharmaceuticals allow developers to swap a therapeutic isotope for an imaging isotope on the same targeting molecule, enabling real-time visual proof of tumor targeting on a PET scan. Furthermore, relying on restricted isotopes from nuclear and defense programs creates natural regulatory and supply-chain barriers that shield Western developers from generic copycats.
• Decentralized Infrastructure Networks (DePIN) in Physical AI: High-precision positioning is vital for autonomous vehicles, drones, and robotics. By leveraging crypto-incentives, startups can crowd-source global infrastructure rollouts—allowing individuals to host inexpensive ground stations in exchange for token rewards—scaling networks faster and at a fraction of the capital expenditure of centralized telecom giants.

Quotes

• At 0:02:29 - "I showed up in New York at Lincoln Center in 2015 and I said Amazon's going to be a trillion-dollar company. And I was laughed out of the room." - Chamath Palihapitiya, highlighting the history of the Sohn Conference and the value of bold, long-term non-consensus ideas.
• At 0:03:52 - "Barry [Diller] now owns 26% of the company... Yesterday he actually bid for the company... I would not sell my stock to him for a second. And the reason is, besides him buying the stock, the company has also been buying the stock." - Aaron Cowen, explaining why MGM Resorts is undervalued and showing the strong insider buying alignment.
• At 0:05:07 - "MGM has two hidden assets... The first one is a license to open a casino in Osaka, Japan." - Aaron Cowen, explaining the untapped value in MGM's expansion portfolio that is not currently priced in by the public market.
• At 0:05:35 - "If you can buy a hard asset at a discount to replacement cost, for an asset that's going to be needed in the future... then you buy that asset... and you sell it at a big premium to replacement cost when the market wakes up." - Dan Dreyfus, explaining the core value-investing thesis behind Talen Energy.
• At 0:08:18 - "The amount of energy that we need for computing is probably 1,000x more than we currently have." - Quote from Nvidia CEO Jensen Huang (presented by Dan Dreyfus), illustrating the astronomical power requirements of next-generation AI.
• At 0:09:47 - "Early surgical cancer treatment and radiation was akin to a medieval siege: level the entire castle, burn the surrounding village, and hope the enemy was left somewhere in the rubble." - Oleg Nodelman, contextualizing how far oncology has progressed compared to historical treatment methods.
• At 0:11:00 - "Modern-day radiopharmaceuticals [are] like a swarm of micro-drones small enough to navigate the bloodstream and find their target by molecular recognition, then detonate a precisely sized warhead... with minimal collateral damage." - Oleg Nodelman, explaining the mechanism of action of Aktis Oncology's platform.
• At 0:29:27 - "The warfare analogy is actually perfect for cancer because both domains are trying to accomplish the exact same thing: find the enemy, figure out the best weapon to kill them, and have minimal unwanted casualties along the way." - Oleg Nodelman, explaining the strategic framework of oncological development.
• At 0:31:02 - "Like a swarm of micro-drones small enough to navigate the bloodstream and find their target by molecular recognition, then detonate a precisely sized warhead... an autonomous assassination with the force of a bunker buster and minimum collateral damage." - Oleg Nodelman, illustrating the mechanics and precision of modern radio-pharmaceuticals.
• At 0:31:54 - "The beautiful thing about this approach is that physicians can verify target engagement in early clinical trials with imaging. This significantly de-risks clinical development because you know the drug is getting to the tumor." - Oleg Nodelman, highlighting the unique diagnostic and therapeutic pairing (theranostics) that lowers development risk.
• At 0:33:27 - "The neatest thing about this modality is that it's very hard to replicate... because the class involves radioisotopes, it's off-limits to China. So unlike most of biotech, there's a real moat." - Oleg Nodelman, describing the geopolitical and supply-chain barriers that protect radio-pharmaceutical companies from rapid generic replication.
• At 0:37:22 - "With a business like this... the guys who work at John Deere know the guys who work at DJI, who know the guys who work at TomTom. And so this thing is now growing virally amongst this core community of customers." - Guest Speaker, explaining the B2B network effects and viral growth loop of localized precision data.
• At 0:41:15 - "Going to space just consumes way more energy than going to a base station that's on the ground... for a tractor maybe that doesn't matter, but for a drone or for any other battery-sensitive application, ground is always going to be the preferred solution." - Guest Speaker, outlining the physics and energy-efficiency constraints that favor ground-based RTK networks over satellite-only alternatives for robotics.

Takeaways

• Look for value-unlock opportunities in undervalued equities by identifying mispriced, high-potential expansion assets, such as MGM's exclusive casino license in Osaka, Japan.
• Capitalize on the AI infrastructure boom by investing in energy providers that possess existing, grid-connected baseload power assets (like nuclear) that cannot be easily replicated due to supply chain bottlenecks.
• De-risk early-stage biotechnology investments by prioritizing platforms that utilize theranostics, allowing immediate visual PET scan verification of target engagement in Phase 1 trials.
• Evaluate the geopolitical and regulatory supply-chain barriers of a healthcare business, focusing on modalities like radiopharmaceuticals that cannot be easily commoditized or replicated in foreign jurisdictions.
• Leverage decentralized physical infrastructure networks (DePIN) to scale hardware-dependent platforms, bypassing the high capital expenditures and long deployment timelines of traditional centralized rollouts.
• Prioritize ground-based RTK (Real-Time Kinematics) positioning networks over satellite-only positioning systems to optimize power efficiency and localization accuracy for battery-sensitive robotics and drones.